Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

8,586 total articles

enGene Therapeutics: Oversold Biotech — A Risk-Adjusted Bounce Trade

enGene Therapeutics: Oversold Biotech — A Risk-Adjusted Bounce Trade

enGene (ENGN) has plunged from a $12.25 peak to under $2. The balance sheet is thin and the company burns cash, but the stock is deeply oversold (RSI 28.5) and trading at a sub-0.4 P/B with an enterprise value below $100M. For traders willing to accept biotech binary risk, a disciplined long with a tight stop and a clear time horizon can offer asym…

Atour Lifestyle: Dividend-Backed Recovery with Room to Run

Atour Lifestyle: Dividend-Backed Recovery with Room to Run

Atour (ATAT) trades below recent highs after a pullback. The company is executing rapid hotel expansion, posted double-digit revenue growth, and just reinforced shareholder returns via dividends and buybacks. A tactical long entry around $33.00 offers an asymmetric risk/reward to $40.00 with a $31.00 stop on a mid-term (45 trading days) horizon.

Amcor: High-Yield Packaging Play with Value Upside

Amcor: High-Yield Packaging Play with Value Upside

Amcor combines a chunky dividend (yield ~6.8%) with steady free cash flow and reasonable valuation metrics (EV/EBITDA ~9.5). The shares have pulled back toward the low of the year while the packaging addressable markets — from sustainable flexible films to pharmaceutical packaging — remain structurally solid. This trade idea buys a yield cushion an…

Nature's Sunshine - Oversold Herbal Play Showing Real Digital Traction

Nature's Sunshine - Oversold Herbal Play Showing Real Digital Traction

Nature's Sunshine (NATR) looks like a classic fundamentals-plus-technical setup: healthy cash flow, no net debt, and clear digital initiatives collide with oversold technicals and rising short interest. We lay out a mid-term trade plan that aims to capture a re-rating back toward prior moving averages while protecting capital on a failure below rec…

Myers Industries: Still Room to Run as FCF and Market Tailwinds Align

Myers Industries: Still Room to Run as FCF and Market Tailwinds Align

Myers Industries (MYE) has recovered strongly from its 2025 lows and is now trading near $23.72. The shares look like a reasonable mid-term long: free cash flow of $88.6M, a sub-$1B market cap, and EV/EBITDA of 9.8 create a valuation backdrop that can support further upside if demand in material handling and returnable packaging continues to expand…

Gen Digital: A 10% Cash-Flow Yield Rethink — Upgrade to Long

Gen Digital: A 10% Cash-Flow Yield Rethink — Upgrade to Long

Gen Digital (GEN) is generating roughly $1.52B in free cash flow against a $15.8B market cap — an effective free-cash-flow yield near 9.6% and a valuation that looks attractive relative to its cash generation. Recent quarters show accelerating revenue and upgraded guidance, management has returned nearly $700M of capital in a quarter, and brand rec…

Buy Dorman Now - Positioned for a Margin Snapback and 20%+ Upside

Buy Dorman Now - Positioned for a Margin Snapback and 20%+ Upside

Dorman Products is a $3.8B aftermarket parts supplier trading at ~20x earnings. Recent cost pressure has weighed on margins, but leadership changes, steady free cash flow ($70.7M), and a product cadence of aftermarket exclusives make a margin recovery credible. Buy into a mid-term swing (45 trading days) to capture a 20%+ move as gross margins norm…

Big Yellow: Why Empty Space Is a High-Conviction Trade Now

Big Yellow: Why Empty Space Is a High-Conviction Trade Now

Big Yellow (BYG) benefits from secular demand for flexible space, pricing power at the store level, and a portfolio that behaves like inflation-adjusted cash flow. I view a tactical long with defined entry, target and stop as an attractive mid-term trade: buy on a measured dip and ride continued cash flow resilience into a re-rating.

Skeena Resources: Buy the Construction Re-rate While It’s Pulling Back

Skeena Resources: Buy the Construction Re-rate While It’s Pulling Back

Skeena (SKE) is an advanced-stage precious metals developer with a fully permitted Eskay Creek project moving into construction. With construction ~49% complete, $750M of senior secured notes closed, and production targeted for Q2 2027, short-term weakness offers a buyable entry to capture a re-rating as the asset transitions toward first ounces. T…